Home > Analytics > AKUMS DRUGS & PHARMACEUTICALS

AKUMS DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 544222     NSE : AKUMS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Sep 11,2026
Price(EOD): ₹ 776.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 12,217.39 Cr
Value of ₹ 1 Lac invested in AKUMS DRUGS & PHARMACEUTICALS
on Aug 06,2024 (price: ₹ 796.35)

₹ 1 L

₹ 0.97 L

1W : 2.8% 1M : 3.3% 1Y : 60.5%
COMMUNITY POLL
for AKUMS DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AKUMS DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
AKUMS DRUGS & PHARMACEUTICALS 2.8% 3.3% 60.5%
SUN PHARMACEUTICAL INDUSTRIES -3% -5.2% 17.9%
DIVIS LABORATORIES 0.2% 9.7% 56.1%
TORRENT PHARMACEUTICALS 1.3% 2% 36.5%
CIPLA -2.2% -6.6% -10.5%
DR REDDYS LABORATORIES 1.4% -3.7% -8.8%
MANKIND PHARMA -1.9% -5.8% -12.9%
LUPIN -0.4% -7.3% 6.6%
ZYDUS LIFESCIENCES -3.1% -4.6% 10.8%

FUNDAMENTAL ANALYSIS OF AKUMS DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2026, Y: Mar2026
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AKUMS DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Sep 11,2026 ]

Ratio Consolidated
P/E
P/B
P/S
41.74
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 292.69 Cr
[Latest Qtr - Jun2026 - Consolidated Results ]

3.69
P/B Calculated based on Book Value of Rs 3,313.35 Cr
[Latest Year - Mar2026 - Consolidated Results ]

2.71
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 4,501.61 Cr
[Latest Qtr - Jun2026 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 68% undervalued companies ! Discover More →

FAIR VALUE OF AKUMS DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
851%
1175%
41%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AKUMS DRUGS & PHARMACEUTICALS



AKUMS DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AKUMS DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2026
2025
2024
Avg_3yrs
0.01
0
1.57
0.53
0.02
0
0.69
0.24
[Last Annual Data : Mar2026]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AKUMS DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AKUMS DRUGS & PHARMACEUTICALS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
0.76%
15.13%
14.87%
24.14%
13.93%
35.44%
45.58%
56.11%
QtrlyTrend
8
Latest Qtr: Jun2026
Quarterly Result Analysis →


AKUMS DRUGS & PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE HEALTHCARE 0.6% 0.5% 15.8%
BSE 1000 -1.5% -2.9% 0.7%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 0.7% 2.1% 13.1%
NIFTY SMALLCAP 500 -0.3% 0.7% NA
NIFTY MIDSMALLCAP400 50:50 -1.1% -1.4% NA
NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX -1.3% -2.3% 4.5%
NIFTY 500 EQUAL WEIGHT -1.4% -2.3% 4.3%

You may also like the below Video Courses


FAQ about AKUMS DRUGS & PHARMACEUTICALS


Is AKUMS DRUGS & PHARMACEUTICALS good for long term investment?

As on Sep 11,2026, the Fundamentals of AKUMS DRUGS & PHARMACEUTICALS look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of AKUMS DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AKUMS DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Sep 11,2026, AKUMS DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS ?

As on Sep 11,2026, the Intrinsic Value of AKUMS DRUGS & PHARMACEUTICALS is Rs. 81.65 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 81.65
Fair Value [Median EV / Sales Model] : Rs. 60.90
Fair Value [Median Price / Sales Model] : Rs. 549.57
Estimated Median Fair Value of AKUMS DRUGS & PHARMACEUTICALS : Rs. 81.65

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AKUMS DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Sep 11,2026, AKUMS DRUGS & PHARMACEUTICALS is trading at a Premium of 851% based on the estimates of Median Intrinsic Value!